These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4391708)

  • 1. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
    Gilmore E; Weil J; Chidsey C
    N Engl J Med; 1970 Mar; 282(10):521-7. PubMed ID: 4391708
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
    Hansson L; Zweifler AJ; Julius S; Ellis CN
    Int J Clin Pharmacol; 1974 Sep; 10(2):79-89. PubMed ID: 4448555
    [No Abstract]   [Full Text] [Related]  

  • 3. Minoxidil--an alternative to nephrectomy for refractory hypertension.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1973 Jul; 289(4):167-71. PubMed ID: 4268267
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102. PubMed ID: 5438435
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.
    Gottlieb TB; Katz FH; Chidsey CA
    Circulation; 1972 Mar; 45(3):571-82. PubMed ID: 4401051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of the antihypertensive action of propranolol].
    Magnani B; Ambrosioni E; Branzi A; Maresta A; Picchio F; Russo F; Sanguinetti M
    Minerva Cardioangiol; 1973 Apr; 21(4):284-97. PubMed ID: 4710125
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic changes in patients with coronary heart disease after beta-adrenergic blockade with propranolol.
    Bürgin D
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):365-70. PubMed ID: 4395489
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102-3. PubMed ID: 4392414
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasodilation in treatment of hypertension.
    Bristow M
    N Engl J Med; 1970 May; 282(19):1102. PubMed ID: 4392413
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic resistance of forearm vessels during prolonged drug treatment of essential hypertension.
    Vitols AV; Skarda IJ; Liepinia DJ; Voita DU; Skards JV
    Cor Vasa; 1990; 32(1):36-44. PubMed ID: 2340728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 20. Radionuclide techniques in studies of cardiac performance and circulatory changes during antihypertensive treatment.
    Falch DK
    J Oslo City Hosp; 1980; 30(9-10):113-36. PubMed ID: 7003079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.